相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Low-dose oral glucocorticoid therapy and risk of osteoporotic fractures in patients with rheumatoid arthritis: a cohort study using the Clinical Practice Research Datalink
Shahab Abtahi et al.
RHEUMATOLOGY (2022)
Loss of glucocorticoid rhythm induces an osteoporotic phenotype in female mice
Maaike Schilperoort et al.
AGING CELL (2021)
Denosumab Discontinuation and the Rebound Phenomenon: A Narrative Review
Athanasios D. Anastasilakis et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Review of Current Real-World Experience with Teriparatide as Treatment of Osteoporosis in Different Patient Groups
Barbara Hauser et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Prevalence of Immunosuppressive Drug Use Among Commercially Insured US Adults, 2018-2019
Beth I. Wallace et al.
JAMA NETWORK OPEN (2021)
Prevention of Glucocorticoid-Induced Osteoporosis Clinical audit to evaluate the implementation of National Osteoporosis Guideline Group 2017 guidelines in a primary care setting
Matthew Carter
JOURNAL OF CLINICAL DENSITOMETRY (2019)
Incident Fragility Fractures Have a Long-Term Negative Impact on Health-Related Quality of Life of Older People: The Canadian Multicentre Osteoporosis Study
Sayem Borhan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
Denosumab Versus Risedronate in Glucocorticoid-Induced Osteoporosis: Final Results of a Twenty-Four-Month Randomized, Double-Blind, Double-Dummy Trial
Kenneth G. Saag et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Glucocorticoid-induced osteoporosis update
Giovanni Adami et al.
CURRENT OPINION IN RHEUMATOLOGY (2019)
Current Treatments and New Developments in the Management of Glucocorticoid-induced Osteoporosis
Hennie G. Raterman et al.
DRUGS (2019)
Update on the safety and efficacy of teriparatide in the treatment of osteoporosis
Salvatore Minisola et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2019)
Effectiveness of Oral Bisphosphonates in Reducing Fracture Risk Among Oral Glucocorticoid Users: Three Matched Cohort Analyses
M. Amine Amiche et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension
Steven R. Cummings et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Use of high-dose intermittent systemic glucocorticoids and the risk of fracture in patients with chronic obstructive pulmonary disease
Olorunfemi A. Oshagbemi et al.
BONE (2018)
Real-world effectiveness of teriparatide on fracture reduction in patients with osteoporosis and comorbidities or risk factors for fractures: Integrated analysis of 4 prospective observational studies
Bente L. Langdahl et al.
BONE (2018)
Glucocorticoids and Bone: Consequences of Endogenous and Exogenous Excess and Replacement Therapy
Rowan S. Hardy et al.
ENDOCRINE REVIEWS (2018)
Glucocorticoid Exposure and Fracture Risk in a Cohort of US Patients With Selected Conditions
Akhila Balasubramanian et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Association Between Glucocorticoid Exposure and Healthcare Expenditures for Potential Glucocorticoid-related Adverse Events in Patients with Rheumatoid Arthritis
Jennie H. Best et al.
JOURNAL OF RHEUMATOLOGY (2018)
Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial
David L. Kendler et al.
LANCET (2018)
Harm, benefit and costs associated with low-dose glucocorticoids added to the treatment strategies for rheumatoid arthritis in elderly patients (GLORIA trial): study protocol for a randomised controlled trial
Linda Hartman et al.
TRIALS (2018)
Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study
Kenneth G. Saag et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Impact of cumulative exposure to high-dose oral glucocorticoids on fracture risk in Denmark: a population-based case-control study
M. Amine Amiche et al.
ARCHIVES OF OSTEOPOROSIS (2018)
Strength measures are better than muscle mass measures in predicting health-related outcomes in older people: time to abandon the term sarcopenia?
J. C. Menant et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases
Athanasios D. Anastasilakis et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study
Akbar K. Waljee et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Determining Risk of Falls in Community Dwelling Older Adults: A Systematic Review and Meta-analysis Using Posttest Probability
Michelle M. Lusardi et al.
JOURNAL OF GERIATRIC PHYSICAL THERAPY (2017)
Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study
Akbar K. Waljee et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Lenore Buckley et al.
ARTHRITIS & RHEUMATOLOGY (2017)
UK clinical guideline for the prevention and treatment of osteoporosis
J. Compston et al.
ARCHIVES OF OSTEOPOROSIS (2017)
Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis
M. A. Amiche et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis
A. Balasubramanian et al.
OSTEOPOROSIS INTERNATIONAL (2016)
MOLECULAR ACTIONS OF GLUCOCORTICOIDS IN CARTILAGE AND BONE DURING HEALTH, DISEASE, AND STEROID THERAPY
Kerstin Hartmann et al.
PHYSIOLOGICAL REVIEWS (2016)
Infection Risk and Safety of Corticosteroid Use
Jameel Youssef et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2016)
A 24-Month Study Evaluating the Efficacy and Safety of Denosumab for the Treatment of Men With Low Bone Mineral Density: Results From the ADAMO Trial
Bente L. Langdahl et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Glucocorticoid-induced osteoporosis management among seniors, by year, sex, and indication, 1996-2012
J. M. Albaum et al.
OSTEOPOROSIS INTERNATIONAL (2015)
Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies
Arnd Kleyer et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment
Jessica L. Hwang et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2014)
Bone Mineral Density Change in Systemic Lupus Erythematosus: A 5-year Followup Study
Tracy Y. Zhu et al.
JOURNAL OF RHEUMATOLOGY (2014)
Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2)
Frank Buttgereit et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus
J. Jacobs et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Prevalence of oral glucocorticoid usage in the United States: A general population perspective
Robert A. Overman et al.
ARTHRITIS CARE & RESEARCH (2013)
Population-Based Trends in Osteoporosis Management after New Initiations of Long-Term Systemic Glucocorticoids (1998-2008)
S. R. Majumdar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis
S. Lekamwasam et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort
Emily McKeown et al.
RHEUMATOLOGY (2012)
Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW)
Adolfo Diez-Perez et al.
BONE (2011)
Glucocorticoid-Induced Bone Disease
Robert S. Weinstein
NEW ENGLAND JOURNAL OF MEDICINE (2011)
An observational study of glucocorticoid-induced osteoporosis prophylaxis in a national cohort of male veterans with rheumatoid arthritis
L. Caplan et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Effects of Teriparatide Versus Alendronate for Treating Glucocorticoid-Induced Osteoporosis Thirty-Six-Month Results of a Randomized, Double-Blind, Controlled Trial
Kenneth G. Saag et al.
ARTHRITIS AND RHEUMATISM (2009)
Secondary osteoporosis in patients with an osteoporotic fracture
C. Kok et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2009)
FRAX (R) and its applications to clinical practice
John A. Kanis et al.
BONE (2009)
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial
David M. Reid et al.
LANCET (2009)
Glucocorticoid-induced osteoporosis: treatment update and review
Lisa-Ann Fraser et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2009)
Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis - A longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice
Wei Yao et al.
ARTHRITIS AND RHEUMATISM (2008)
Fracture risk associated with different types of oral corticosteroids and effect of termination of corticosteroids on the risk of fractures
Peter Vestergaard et al.
CALCIFIED TISSUE INTERNATIONAL (2008)
Teriparatide or alendronate in glucocorticoid-induced osteoporosis
Kenneth G. Saag et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Glucocorticoid-induced osteoporosis: pathophysiology and therapy
E. Canalis et al.
OSTEOPOROSIS INTERNATIONAL (2007)
Fracture risk with intermittent high-dose oral glucocorticoid therapy
Frank de Vries et al.
ARTHRITIS AND RHEUMATISM (2007)
Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density
D. Jia et al.
ENDOCRINOLOGY (2006)
Glucocorticoids suppress bone formation via the osteoclast
Hyun-Ju Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: A cross-sectional outpatient study
Alberto Angeli et al.
BONE (2006)
Practice patterns in patients at risk for glucocorticoid-induced osteoporosis
AC Feldstein et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients
JR Curtis et al.
ARTHRITIS AND RHEUMATISM (2005)
Influence of glucocorticoids on human osteoclast generation and activity
S Sivagurunathan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength
CA O'Brien et al.
ENDOCRINOLOGY (2004)
Densitometry in glucocorticoid-induced osteoporosis
M Maricic et al.
JOURNAL OF CLINICAL DENSITOMETRY (2004)
A meta-analysis of prior corticosteroid use and fracture risk
JA Kanis et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis - Rates and predictors of care in an academic rheumatology practice
DH Solomon et al.
ARTHRITIS AND RHEUMATISM (2002)
The role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: A re-examination of the evidence
MR Rubin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Effects of cortisol and bone morphogenetic protein-2 on stromal cell differentiation: Correlation with CCAAT-enhancer binding protein expression
RC Pereira et al.
BONE (2002)
The epidemiology of corticosteroid-induced osteoporosis: A meta-analysis
TP van Staa et al.
OSTEOPOROSIS INTERNATIONAL (2002)
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
RM Neer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Economic implications of hip fracture: Health service use, institutional care and cost in Canada
ME Wiktorowicz et al.
OSTEOPOROSIS INTERNATIONAL (2001)
Oral corticosteroids and fracture risk: relationship to daily and cumulative doses
TP van Staa et al.
RHEUMATOLOGY (2000)
Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: A randomized trial
DM Reid et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
分享论文
